Clinical trial · Interventional
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis. Qualitative Observational and Interventional Cross-sectional Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Currently, the EXOMA2 study (NCT04614480) offers earlier and more comprehensive exome analysis in the management of cancer patients than EXOMA. Based on the active EXOMA2 patient file, the INFOGene study offers the opportunity to study patient-physician communication, to assess patient preferences with regard to different information modalities concerning theranostic exome analysis, and to reflect on information modalities to ensure optimal patient comprehension of the information provided. The qualitative cross-sectional study includes a dual observational and interventional component involving cancer patients. The patients will come from the EXOMA 2 active file at Dijon University Hospital and the CGFL.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| 1st-line Treatment | — | UNRESOLVED | — |
| Active File EXOMA2 Study | — | UNRESOLVED | — |
| All Types of Metastatic Solid Malignancy | — | UNRESOLVED | — |
| Exome Analysis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer patients' preferences regarding genetic information modalities prior to theranostic exome analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- OTHER
- label
- Phase 1:Observe communication between physicians and cancer patients
- description
- * Observation of the 10 consultations : To ensure heterogeneous sampling, a varied panel of prescribing physicians will be selected, taking into account gender, age and specialty (oncologist versus organ specialist). * Conduct a semi-structured interview within 10 days of the consultation with 10 new patients who have been prescribed a theranostic exome analysis by a researcher * Thematic content analysis of 10 consultation observations by SHS researchers and 10 semi-structured interviews which will enable us to assess the degree of understanding of the information provided by the doctor, and whether it answers the patient's questions.
- interventionNames
- Other: Cancer patients' preferences regarding genetic information modalities prior to theranostic exome analysis
- type
- NO_INTERVENTION
- label
- Phase 2 : Revisit existing information media (GGC information note and video).
- description
- These materials will serve as a basis for our work, and may be adapted according to the results of phase 1 of our study. We will seek the advice of a partner patient, who will himself have benefited from a genetic analysis in the context of cancer, and who will be made aware of clinical research.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient identified for inclusion in the EXOMA 2 study (exome analysis request) * Available to receive different types of information * Fluent in French * No prior oncogenetic consultation * Having been informed of the objectives of the study and having given written non-objection to participate in the INFOGene study * Authorizing audio recording of consultations and interviews Exclusion Criteria: * Patient who refused to participate in the EXOMA2 study (for phase 3 patients only) * Has a psychiatric, cognitive or neurological disorder that makes participation impossible * Working in the field of genetics
References
Publications (0)
Data not yet available